Tackling the hepatitis C cost problem: A test case for tomorrow's cures

E-ISSN： 1527-3350|62|5|1334-1336

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.5, 2015-11, pp. : 1334-1336

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The case for cost‐effectively treating cryoglobulinemic vasculitis with interferon‐free anti–hepatitis C virus therapy

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 975-975

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir in the treatment of patients with hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 376-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of strategies for testing current hepatitis C virus infection

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1396-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Screening blood donors for hepatitis C virus: the challenge to consider cost‐effectiveness

TRANSFUSION, Vol. 55, Iss. 6, 2015-06 ,pp. : 1143-1146

John Wiley & Sons Inc

Access to resources Recommend Favorite